about
Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic ImplicationsCurrent approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors.Rat Model of Parkes Weber Syndrome.Pharmacophore guided discovery of small-molecule interleukin 15 inhibitors.The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes.Sdf-1 (CXCL12) induces CD9 expression in stem cells engaged in muscle regeneration.Stem cells migration during skeletal muscle regeneration - the role of Sdf-1/Cxcr4 and Sdf-1/Cxcr7 axis.Carcinoembryonic antigen and cytokeratin 20 in peritoneal cells of cancer patients: are we aware of what we are detecting by mRNA examination?The relevance of RT-PCR markers for metastatic tumour cell detection.The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma.The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinoma.Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma.Uterine tumors resembling ovarian sex cord tumors, a clinicopathologic study of six cases.Lack of microsatellite instability in squamous cell vulvar carcinoma.Somatic mutation profiling of vulvar cancer: Exploring therapeutic targetsSystemic inflammation as a confounding factor in cancer biomarker discovery and validationSdf-1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cellsTechnetium-99m-based Radiopharmaceuticals in Sentinel Lymph Node Biopsy: Gynecologic Oncology Perspective
P50
Q28554614-596E437C-5875-45C7-9077-FB1903F9BDFEQ30234454-79081A9F-476D-41EA-955F-5E3A42E53191Q35719115-08763FF7-020D-451E-87B1-3B9F00AE70E1Q38768779-5B10886B-FBE5-48D2-8987-E30DC6F7E82BQ40231304-ACB0E195-43CE-4A9E-9011-5A1FEF0990F1Q41137706-BE58E019-CB49-46FF-B8E0-366974BAE3BAQ41510232-2D00DDAC-8B07-4D4A-A06C-5D0A332BF966Q42746766-E0A2C48D-1FED-424F-8322-4726AC3E25F9Q43005601-D4FEE14E-8E0C-4D52-87C6-563C83906DAEQ43239380-6298D419-877B-4F86-A83C-97C7C6A4691DQ44565703-6BB77B2E-40F0-420E-9807-8C07283EA792Q47547453-51E91FE7-C149-4E44-A5E7-AC85FA10BE2AQ48597121-04F6A891-326A-4C4B-8275-12FF14AE53FBQ53278316-E2FED234-2FD2-4549-ADFA-D5BB3E0DF711Q59357513-37816864-D50F-4725-B0CA-3546BACDBF68Q82401959-D36A8CED-E99D-4F43-8234-1D83EF06E4FDQ84973601-58528F5B-1CCF-4D8F-A3ED-696D02DFD3C2Q88689358-BB8E37B9-9D97-477D-8617-C41EE4C3D58E
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Magdalena Kowalewska
@ast
Magdalena Kowalewska
@en
Magdalena Kowalewska
@es
Magdalena Kowalewska
@nl
type
label
Magdalena Kowalewska
@ast
Magdalena Kowalewska
@en
Magdalena Kowalewska
@es
Magdalena Kowalewska
@nl
prefLabel
Magdalena Kowalewska
@ast
Magdalena Kowalewska
@en
Magdalena Kowalewska
@es
Magdalena Kowalewska
@nl
P1153
8545609500
P31
P496
0000-0002-3413-9612